Abstract
There is a high level of interest in polyunsaturated fatty acids (PUFAs) because of their purported health benefits, especially docosahexaenoic acid (DHA). But a high intake of them may increase the susceptibility to lipid peroxidation of a biological system. Lipid peroxidation has been implicated in the pathogenesis of numerous diseases including atherosclerosis, diabetes, cancer and aging. It is well established that the end-products of lipid peroxidation cause protein damage by means of reactions with lysine amino groups, cysteine sulfhydryl groups, and histidine imidazole groups. PUFAs in tissue are important sources for the formation of endogenous protein adducts, the relative contribution of different PUFAs in the formation of these protein adducts has been reviewed.
Keywords: Lipid peroxidation, protein modification, free radical, reactive aldehyde
Current Proteomics
Title: Protein Modification by Peroxidative Products of Polyunsaturated Fatty Acids
Volume: 5 Issue: 1
Author(s): Wei Liu and Jin-Ye Wang
Affiliation:
Keywords: Lipid peroxidation, protein modification, free radical, reactive aldehyde
Abstract: There is a high level of interest in polyunsaturated fatty acids (PUFAs) because of their purported health benefits, especially docosahexaenoic acid (DHA). But a high intake of them may increase the susceptibility to lipid peroxidation of a biological system. Lipid peroxidation has been implicated in the pathogenesis of numerous diseases including atherosclerosis, diabetes, cancer and aging. It is well established that the end-products of lipid peroxidation cause protein damage by means of reactions with lysine amino groups, cysteine sulfhydryl groups, and histidine imidazole groups. PUFAs in tissue are important sources for the formation of endogenous protein adducts, the relative contribution of different PUFAs in the formation of these protein adducts has been reviewed.
Export Options
About this article
Cite this article as:
Liu Wei and Wang Jin-Ye, Protein Modification by Peroxidative Products of Polyunsaturated Fatty Acids, Current Proteomics 2008; 5 (1) . https://dx.doi.org/10.2174/157016408783955119
DOI https://dx.doi.org/10.2174/157016408783955119 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases
Current Pharmaceutical Design Carotenoids of Microalgae Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Nephro-Protective Effect of Cortex Lycii Radicis Extracts in Streptozotocin- Induced Diabetic Rats
Current Signal Transduction Therapy Does More MnSOD Mean More Hydrogen Peroxide?
Anti-Cancer Agents in Medicinal Chemistry Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
CNS & Neurological Disorders - Drug Targets Application of Sulfamic Acid in Organic Synthesis-A Short Review
Current Organic Chemistry Functional Multipotency of Stem Cells: A Conceptual Review of Neurotrophic Factor-Based Evidence and Its Role in Translational Research
Current Neuropharmacology Flavonoids in Human Health: From Structure to Biological Activity
Current Nutrition & Food Science Role of Vascular Endothelial Growth Factor in Kidney Disease
Current Vascular Pharmacology Chalcones and <i>Bis</i>-Chalcones Analogs as DPPH and ABTS Radical Scavengers
Letters in Drug Design & Discovery Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders
Central Nervous System Agents in Medicinal Chemistry Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
CNS & Neurological Disorders - Drug Targets State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Enriching One’s Environment in the Face of Cognitive and Functional Loss
Current Neurovascular Research Role of Hexokinase and VDAC in Neurological Disorders
Current Molecular Pharmacology Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research Ion Channels on Microglia: Therapeutic Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Special Issue in Memory of Prof. Dr. Luis Eduardo Diaz: Current Topics in Pharmaceutical Biotechnology)
Current Pharmaceutical Biotechnology Eye Disorders in Diabetes: Potential Drug Targets
Infectious Disorders - Drug Targets